Astellas files US patent claims against generic pharmaceutical companies over Myrbetriq
MLex Summary: Astellas Pharma filed a US patent complaint against Lupin, Sandoz, and other companies over Myrbetriq extended-release tablets.See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article